ENDLOS-TURBO PUT - BIOGEN IDEC | Real-time Boerse Frankfurt Warrants 12:04:34 2024-05-23 EDT | ||
| 13.24 EUR | +4.01% |
|
| Current month | -8.68% | ||
| 1 month | -19.94% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Chart
BIOGEN INC.
Latest news about BIOGEN INC.
More news
| Date | Price | Change |
|---|---|---|
| 24-05-23 | 13.24 | +4.01% |
| 24-05-22 | 12.73 | +1.92% |
| 24-05-21 | 12.49 | +2.55% |
| 24-05-20 | 12.18 | -0.57% |
| 24-05-17 | 12.25 | -0.49% |
Real-time Boerse Frankfurt Warrants
Last update May 23, 2024 at 12:04 pm
More quotesStatic data
| Product type | Knock-Out without Stop Loss |
|---|---|
| Buy / Sell | PUT |
| Underlying | BIOGEN INC. |
| Issuer | DZ BANK |
| WKN | DJ7M6A |
| ISIN | DE000DJ7M6A5 |
| Date issued | 2023-12-15 |
| Strike | 360.6 $ |
| Maturity | Unlimited |
| Parity | 10 : 1 |
| Emission price | 9.412 € |
| Emission volume | N/A |
| Settlement | cash |
| Currency | EUR |
Technical Indicators
| Highest since issue | 16.29 € |
|---|---|
| Lowest since issue | 8.62 € |
| Spread | 0.01 € |
| Spread % | 0.08% |
Company Profile
Biogen Inc. is one of the world's leaders in the design, manufacturing, and marketing of therapeutic products. Net sales break down by source of income as follows:
- sales of medicines (73,7%): for treating multiple sclerosis, chronic psoriasis in adults, rheumatoid arthritis, cancers, etc.;
- royalties (17,2%) ;
- other (9,1%): primarily revenues from partnership agreements.
Sector
-
Consensus: Biogen Inc.
Sell
Buy
Mean consensus
BUY
Number of Analysts
33
Last Close Price
225.2
USD
Average target price
287.3
USD
Spread / Average Target
+27.57%
- Stock Market
- Certificates
- Certificat
